We present autopsy findings of a 22-year-old man who developed chest pain 5 days after
the first dose of the BNT162b2 mRNA vaccine and died 7 hours later. Histological …

A 14-year-old Japanese girl died unexpectedly 2 days after receiving the third dose of the
BNT1262b2 mRNA COVID-19 vaccine. Autopsy findings showed congestive edema of the …

Importance The BNT162b2 (Pfizer-BioNTech) messenger RNA COVID-19 vaccine was
authorized on May 10, 2021, for emergency use in children aged 12 years and older. Initial …

Background Clinical trials of the BNT162b2 vaccine, revealed efficacy and safety. We report
six cases of myocarditis, which occurred shortly after BNT162b2 vaccination. Methods …

Abstract Background Approximately 5.1 million Israelis had been fully immunized against
coronavirus disease 2019 (Covid-19) after receiving two doses of the BNT162b2 messenger …

Myocarditis following mRNA COVID-19 vaccination has recently been reported to health
authorities in the United States and other countries. Cases predominately occur in young …

Objective: Unusual clinical course Background: The COVID-19 pandemic is a current global
crisis, and there are hundreds of millions of individuals being vaccinated worldwide. At …

Acute myocarditis following mRNA COVID‐19 vaccination was reported by the European
Medicine Agency safety committee as a rare adverse event. We present a case series of …

3. Calderó n J, Sandoval J, Beltrá n M. Hipertensió n pulmonar asociada con cardiopatıas
congé nitas y sındrome de Eisenmenger. Arch Cardiol Mex. 2015; 85: 32–49. 4. van der …

(COVID-19) vaccines have gained widespread use across the globe to prevent further
spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Early …